DIAGNOS Inc.
TSX VENTURE : ADK

DIAGNOS Inc.

September 11, 2013 09:30 ET

DIAGNOS Completes $2.2 Million Exploration Mission Under Quebec's Plan Nord

BROSSARD, QUEBEC--(Marketwired - Sept. 11, 2013) - DIAGNOS inc. ("DIAGNOS" or the "Corporation") (TSX VENTURE:ADK), a leader in knowledge extraction and artificial intelligence technology, is pleased to announce that it has just completed the exploration mandate in three sectors totaling 1,924 claims that were prospected in Schefferville, Puvirnituq and Lac Pau under Quebec's Plan Nord.

The $2.2 million contract for that mandate, for its Ontario partner, was announced in the June 30, 2013 press release. So far, only a portion of the designated claims totaling 5,242 claims based on a project spanning over 304,000 square kilometers, has been explored.

The mission, which lasted close to two months on properties near Schefferville and Lac Pau and one month for the Puvirnituq property, is a qualified success for Diagnos. A total number of 3,055 samples were collected from 2,197 outcrops by teams of geologists specializing in those territories and will be sent to an independent laboratory for analysis. The most important findings will be announced in the coming weeks. DIAGNOS used its exclusive Computer Aided Resources Detection System (CARDS) to identify the mineral potential in that part of Quebec's far north, a remote region with few staked claims.

About DIAGNOS

Founded in 1998, DIAGNOS is a publicly traded Canadian corporation (TSX VENTURE:ADK), with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including healthcare and natural resources.

Forward-looking statement

This document contains forward-looking information. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in these statements.

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information on DIAGNOS, please visit our website at www.diagnos.com or the SEDAR website at www.sedar.com.

Contact Information